Cell Cryopreservation Market, By Product Type (Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others), By Application (Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others), By End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others), and By Region (North America, Latin America, Europe, Middle East, Asia Pacific, Africa) - Trends, Analysis and Forecast till 2034

Cell Cryopreservation   Market was valued at US$ 11.1 Billion in 2024 and is projected to grow at a CAGR of 21.00% to reach US$ 75.1 Billion by 2034.

Cryopreservation is the technique of freezing tissues and cells at low temperatures, i.e. -80 °C using solid CO2 or -196 °C using liquid nitrogen. To keep the biological material metabolically inert, retain their structure, to maintain its viability, and to prevent ice crystal formation due to low temperature. The cells are preserved in the cryopreservation media that consists of base medium, cryopreservative and a protein source.

                     For More Report Details, Download Free Sample PDF

Regional Insights:                                                                                                                             

On region the target market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa

• North America market is estimated to witness a significantly high revenue share over the forecast period.

                o Advanced medical infrastructure

                 o Significant players in biopharmaceutical industry

                 o Established supply channels

• Asia Pacific market is estimated to witness a fastest revenue share over the forecast period.

                 o Adoption of cell preservation technologies

                 o Surge in rate of infertility

Dividing this target market into segments:

Cell cryopreservation market is segmented based on Product Type, Application, End-user and Region.

Product Type Insight

On the basis of Product Type, the target market is segmented into Cryopreservative Medium (Glycerol, Dimethyl sulfoxide (DMSO), and Others), Freezers, and Others

Application Insight

On the basis of Application, the target market is segmented into Stem cells, Oocytes and embryos, Sperm, Semen, and Testicular Tissue, and Others

End-user Insight

On the basis of End-user, the target market is segmented into Pharmaceutical and Biotechnology Companies, Research Institutes, and Others.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034.

The key players operating in the cell cryopreservation market Merck KGaA, GE Healthcare, Thermo Fisher Scientific, Inc., AMS Biotechnology Limited, Nippon Genetics, VitriCell SA, MiltenyiBiotec, Mediatech, Inc., BioLifeSolutions, Inc., HiMedia Laboratories, and PromoCell GmbH.

Recent Development:

The New Launched Product News,

• In June 2023, BioLife Solutions, Inc., a global biotechnology company, announced the launch of a new, large-capacity controlled-rate freezer (CRF) to expand its CRF product line, which now stands at three different form factors. Branded as the IntelliRate i67C, this tabletop freezer caters to a crucial customer need for higher volume production of cell therapies.
• In May 2022, Bristol Myers Squibb Receives European Commission Approval for CAR T Cell Therapy Breyanzi (lisocabtagene maraleucel) for Certain Forms of Relapsed or Refractory Large B-cell Lymphoma. Breyanzi represents a differentiated CAR T cell therapy with demonstrated rapid and durable complete responses and a manageable safety profile.